Sysmex Corp (6869) – Company Profile and SWOT Analysis

Sysmex Corp (6869) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sysmex Corp (Sysmex) is a provider of medical devices that researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. It offers diagnostic instruments, reagents and laboratory information systems to clinical laboratories for testing. The company’s offerings include haematology, haemostasis, and urinalysis analyzers. Its products are used by medical institutions. It conducts research and development at its facilities in Japan, France, New Zealand, Germany and the US. The company operates along with its subsidiaries in the Americas, Europe, the Middle East, Africa, and Asia Pacific. Sysmex is headquartered in Hyogo, Japan.

Scope

• Detailed information on Sysmex Corp required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Sysmex Corp in the form of a SWOT analysis

• An in-depth view of the business model of Sysmex Corp including a breakdown and examination of key business segments

• News about Sysmex Corp, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Sysmex Corp and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Sysmex Corp as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Sysmex Corps business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Yagami Inc

Alere Inc

Siemens Healthineers AG

Bayer Healthcare LLC, Diabetes Care Division

F. Hoffmann-La Roche Ltd

Cytek Biosciences Inc

Beckman Coulter Inc

bioMerieux SA

Bio-Rad Laboratories Inc

Becton Dickinson and Co

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Sysmex Corp - Key Facts

Sysmex Corp - Key Employees

Sysmex Corp - Key Employee Biographies

Sysmex Corp - Major Products and Services

Sysmex Corp - History

Sysmex Corp - Company Statement

Sysmex Corp - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2 – Company Analysis

Company Overview

Sysmex Corp - Business Description

Business Segment: Diagnostics Business

Overview

Performance

Business Segment: Medical Robotics Business

Overview

Performance

Geographical Segment: Americas

Performance

Geographical Segment: Asia Pacific

Performance

Geographical Segment: China

Performance

Geographical Segment: EMEA

Performance

Geographical Segment: Japan

Performance

R&D Overview

Sysmex Corp - Corporate Strategy

Sysmex Corp - SWOT Analysis

SWOT Analysis - Overview

Sysmex Corp - Strengths

Sysmex Corp - Weaknesses

Sysmex Corp - Opportunities

Sysmex Corp - Threats

Sysmex Corp - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Sysmex Corp, Medical Equipment, Deals By Year, 2018 to YTD 2024

Sysmex Corp, Medical Equipment, Deals By Type, 2018 to YTD 2024

Sysmex Corp, Recent Deals Summary

Section 5 – Company’s Recent Developments

Sep 25, 2024: Sysmex Corp : Announcement of Executive Change

Aug 06, 2024: Sysmex Expands Strategic Alliance Agreement with QIAGEN in the Field of Genetic Testing

Aug 06, 2024: Sysmex Corp : Summary of Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2025

Aug 01, 2024: Sysmex Group’s Largest Manufacturing Base Completed in India

Jul 29, 2024: Sysmex Corporation Selected as a Constituent of All ESG Indices Adopted by the GPIF

Jul 25, 2024: Sysmex Approved by the Science Based Targets initiative

Jul 10, 2024: Sysmex America to Exhibit Latest Automation & Innovation for Workflow Efficiency at ADLM 2024

Jun 04, 2024: Regarding an On-Site Inspection by the Japan Fair Trade Commission

May 11, 2024: Sysmex Group Formulates a Long-Term Corporate Strategy and Mid-Term Management Plan

May 09, 2024: Sysmex : Summary of Consolidated Financial Results [ IFRS ] for the Fiscal Year Ended March 31, 2024

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Sysmex Corp, Key Facts

Sysmex Corp, Key Employees

Sysmex Corp, Key Employee Biographies

Sysmex Corp, Major Products and Services

Sysmex Corp, History

Sysmex Corp, Subsidiaries

Sysmex Corp, Joint Venture

Sysmex Corp, Key Competitors

Sysmex Corp, Ratios based on current share price

Sysmex Corp, Annual Ratios

Sysmex Corp, Annual Ratios (Cont…1)

Sysmex Corp, Annual Ratios (Cont…2)

Sysmex Corp, Interim Ratios

Sysmex Corp, Medical Equipment, Deals By Year, 2018 to YTD 2024

Sysmex Corp, Medical Equipment, Deals By Type, 2018 to YTD 2024

Sysmex Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Sysmex Corp, Performance Chart (2020 – 2024)

Sysmex Corp, Ratio Charts

Sysmex Corp, Medical Equipment, Deals By Year, 2018 to YTD 2024

Sysmex Corp, Medical Equipment, Deals by Type, 2018 to YTD 2024

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports